Sinoway Industrial Co., Ltd.

Lenvatinib 857890-39-2 Lenvatinib 857890-39-2

Lenvatinib 857890-39-2
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Lenvatinib

Name

Lenvatinib

Alias

Lenvatinib Mesylate

CAS NO.

857890-39-2

Molecular Formula

C21H19ClN4O4.CH4O3S

Quality Standard

EP

Grade Standard

Medicine grade  / 99% min

Package Size

10g/bag

Use of Lenvatinib

Levartinib is a kinase inhibitor and a multi-target oral targeting drug for a variety of malignancies. Since 2015, Levartini has been approved by the FDA for the treatment of advanced thyroid cancer and kidney cancer; and in recent years, the treatment of liver cancer has also achieved remarkable results, in addition to Levantinib for non-small cell lung cancer Clinical trials of solid tumors such as gliomas and endometrial cancers are also underway.

COA of Lenvatinib

Test items

Specifications

Appearance

Pale yellow towhite powder

Loss on drying

NMT0.5%

Residue on Ignition

NMT0.5%

Individual impurity

NMT0.5%

Total impurities

NMT1.0%

Purity

NLT 99.0%

Conclusion

The product tested complies with the specifications




  • Ezetimibe 163222-33-1
    Basic information of Ezetimibe :NameEzetimibeCAS :163222-33-1Molecular FormulaC24H21F2NO3Molecular Weight409.43Quality StandardIn house standard. 98%-102%Package SizeFor small quantity:Double plastic ... Ezetimibe 163222-33-1
  • Imatinib Mesylate 220127-57-1
    Basic information of Imatinib Mesylate:NameImatinib MesylateAliasGLIVEC;GLEEVEC;IMATINIB METHANESULFONATE; CGP-57148B; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)a... Imatinib Mesylate 220127-57-1
  • Pemetrexed Disodium 357166-30-4
    Basic information of Pemetrexed disodium:NamePemetrexed disodiumAliasPemetrexed disodium for Injection; Pemetrexed Disodium 2.5 hydrate; Pemetrexed Disodium7 hydrateCAS NO.357166-30-4Molecular Formula... Pemetrexed Disodium 357166-30-4
  • Tenofovir disoproxil fumarate 202138-50-9
    Basic information of Tenofovir disoproxil fumarateNameTenofovir disoproxil fumarateAlias(((((1-(6-aMino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) diisopropyl dicarbonate ... Tenofovir disoproxil fumarate 202138-50-9

MORE_DETAIL Lenvatinib 857890-39-2

Basic information of Lenvatinib

Name

Lenvatinib

Alias

Lenvatinib Mesylate

CAS NO.

857890-39-2

Molecular Formula

C21H19ClN4O4.CH4O3S

Quality Standard

EP

Grade Standard

Medicine grade  / 99% min

Package Size

10g/bag

Use of Lenvatinib

Levartinib is a kinase inhibitor and a multi-target oral targeting drug for a variety of malignancies. Since 2015, Levartini has been approved by the FDA for the treatment of advanced thyroid cancer and kidney cancer; and in recent years, the treatment of liver cancer has also achieved remarkable results, in addition to Levantinib for non-small cell lung cancer Clinical trials of solid tumors such as gliomas and endometrial cancers are also underway.

COA of Lenvatinib

Test items

Specifications

Appearance

Pale yellow towhite powder

Loss on drying

NMT0.5%

Residue on Ignition

NMT0.5%

Individual impurity

NMT0.5%

Total impurities

NMT1.0%

Purity

NLT 99.0%

Conclusion

The product tested complies with the specifications



Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//